Aikenist, a provider of Gen-AI-based smart workflow solutions, has raised an undisclosed amount in a seed round led by Venture Catalysts.
Several well-known investors, including MARL Fund, Quant Fund, C-CAMP, Nandak Growth Catalysts, and angel investors, participated in the funding round and contributed significant knowledge and resources to support Aikenist’s trajectory of growth.
Aikenist, founded by Ashwin Amarapur, offers hospitals and diagnostic centers AI-accelerated magnetic resonance imaging (MRIs). With the help of cutting-edge AI-based technologies, Aikenist hopes to increase the number of people who can benefit from routine medical imaging exams for serious conditions like cancer, Alzheimer’s disease, and common MSK issues. These include quicker MRI scanning times, improved diagnosis capabilities, and quicker turnaround times.
The company’s software as a service (SaaS) business model offers healthcare providers of all sizes flexibility through annual pricing or pay-per-use options, ranging from small clinics to large hospital networks.
The main product from Aikenist, QuickSuite, streamlines all radiology procedures, including the acquisition, analysis, reporting, and sharing of scan data. QuickRad, an AI-powered PACS & RIS system; QuickScan, a patented solution for expedited MRI scanning; and QuickDiag, a suite of specialized suites for disease detection and quantification, make up the solution.
